{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T08:31:35Z","timestamp":1722587495347},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,23]]},"DOI":"10.7759\/cureus.18985","type":"journal-article","created":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T10:56:43Z","timestamp":1634986603000},"source":"Crossref","is-referenced-by-count":5,"title":["A Case of Idiopathic Thrombocytopenic Purpura After Booster Dose of BNT162b2 (Pfizer-Biontech) COVID-19 Vaccine"],"prefix":"10.7759","author":[{"given":"Srikrishna V","family":"Malayala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavani N","family":"Papudesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urwat T","family":"Vusqa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambreen","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr4490","article-title":"Review of COVID-19 vaccines approved in the United States of America for emergency use","volume":"13","author":"Vasireddy D","year":"2021","unstructured":"Vasireddy D, Atluri P, Malayala SV, Vanaparthy R, Mohan G. Review of COVID-19 vaccines approved in the United States of America for emergency use. J Clin Med Res. 2021, 13:204-13. 10.14740\/jocmr4490","journal-title":"J Clin Med Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr4518","article-title":"Review of COVID-19 variants and COVID-19 vaccine efficacy: what the clinician should know?","volume":"13","author":"Vasireddy D","year":"2021","unstructured":"Vasireddy D, Vanaparthy R, Mohan G, Malayala SV, Atluri P. Review of COVID-19 variants and COVID-19 vaccine efficacy: what the clinician should know?. J Clin Med Res. 2021, 13:317-25. 10.14740\/jocmr4518","journal-title":"J Clin Med Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.04.047","article-title":"Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers","volume":"106","author":"Kadali RA","year":"2021","unstructured":"Kadali RA, Janagama R, Peruru S, Malayala SV. Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers. Int J Infect Dis. 2021, 106:376-81. 10.1016\/j.ijid.2021.04.047","journal-title":"Int J Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26996","article-title":"Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: a randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms","volume":"93","author":"Kadali RA","year":"2021","unstructured":"Kadali RA, Janagama R, Peruru S, Gajula V, Madathala RR, Chennaiahgari N, Malayala SV. Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: a randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms. J Med Virol. 2021, 93:4420-9. 10.1002\/jmv.26996","journal-title":"J Med Virol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01419-1","article-title":"COVID-19 vaccination and immune thrombocytopenia","volume":"27","author":"Pishko AM","year":"2021","unstructured":"Pishko AM, Bussel JB, Cines DB. COVID-19 vaccination and immune thrombocytopenia. Nat Med. 2021, 27:1145-6. 10.1038\/s41591-021-01419-1","journal-title":"Nat Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14099","article-title":"Purpuric rash and thrombocytopenia after the mRNA-1273 (Moderna) COVID-19 vaccine","volume":"13","author":"Malayala SV","year":"2021","unstructured":"Malayala SV, Mohan G, Vasireddy D, Atluri P. Purpuric rash and thrombocytopenia after the mRNA-1273 (Moderna) COVID-19 vaccine. Cureus. 2021, 13:e14099. 10.7759\/cureus.14099","journal-title":"Cureus"},{"key":"ref7","unstructured":"Who is eligible for a COVID-19 vaccine booster shot?. (2021). Accessed. October 15, 2021: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/booster-shot.html."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.01.030","article-title":"Allergic reactions and anaphylaxis to LNP-based COVID-19 vaccines","volume":"29","author":"Moghimi SM","year":"2021","unstructured":"Moghimi SM. Allergic reactions and anaphylaxis to LNP-based COVID-19 vaccines. Mol Ther. 2021, 29:898-900. 10.1016\/j.ymthe.2021.01.030","journal-title":"Mol Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17942","article-title":"Immune thrombocytopenia exacerbation after COVID-19 vaccination in a young woman","volume":"13","author":"Fujita M","year":"2021","unstructured":"Fujita M, Ureshino H, Sugihara A, Nishioka A, Kimura S. Immune thrombocytopenia exacerbation after COVID-19 vaccination in a young woman. Cureus. 2021, 13:e17942. 10.7759\/cureus.17942","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.04.054","article-title":"Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)","volume":"39","author":"Welsh KJ","year":"2021","unstructured":"Welsh KJ, Baumblatt J, Chege W, Goud R, Nair N. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2021, 39:3329-32. 10.1016\/j.vaccine.2021.04.054","journal-title":"Vaccine"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2105869","article-title":"Thrombotic thrombocytopenia after Ad26.COV2.S vaccination","volume":"384","author":"Muir KL","year":"2021","unstructured":"Muir KL, Kallam A, Koepsell SA, Gundabolu K. Thrombotic thrombocytopenia after Ad26.COV2.S vaccination. N Engl J Med. 2021, 384:1964-5. 10.1056\/NEJMc2105869","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04889.x","article-title":"The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura","volume":"125","author":"Cooper N","year":"2004","unstructured":"Cooper N, Stasi R, Cunningham-Rundles S, Feuerstein MA, Leonard JP, Amadori S, Bussel JB. The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Br J Haematol. 2004, 125:232-9. 10.1111\/j.1365-2141.2004.04889.x","journal-title":"Br J Haematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26132","article-title":"Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination","volume":"96","author":"Lee EJ","year":"2021","unstructured":"Lee EJ, Cines DB, Gernsheimer T, et al.. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol. 2021, 96:534-7. 10.1002\/ajh.26132","journal-title":"Am J Hematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher A","year":"2021","unstructured":"Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021, 384:2092-101. 10.1056\/NEJMoa2104840","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz NH","year":"2021","unstructured":"Schultz NH, S\u00f8rvoll IH, Michelsen AE, et al.. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021, 384:2124-30. 10.1056\/NEJMoa2104882","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012064","article-title":"A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination","volume":"137","author":"Handtke S","year":"2021","unstructured":"Handtke S, Wolff M, Zaninetti C, et al.. A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination. Blood. 2021, 137:3656-9. 10.1182\/blood.2021012064","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/73722-a-case-of-idiopathic-thrombocytopenic-purpura-after-booster-dose-of-bnt162b2-pfizer-biontech-covid-19-vaccine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:51Z","timestamp":1707507351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/73722-a-case-of-idiopathic-thrombocytopenic-purpura-after-booster-dose-of-bnt162b2-pfizer-biontech-covid-19-vaccine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,23]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.18985","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,23]]}}}